scholarly journals Postmarketing Surveillance Study of Erlotinib in Japanese Patients With Non–Small-Cell Lung Cancer (NSCLC): An Interim Analysis of 3488 Patients (POLARSTAR)

2012 ◽  
Vol 7 (8) ◽  
pp. 1296-1303 ◽  
Author(s):  
Kazuhiko Nakagawa ◽  
Shoji Kudoh ◽  
Yuichiro Ohe ◽  
Takeshi Johkoh ◽  
Masahiko Ando ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Interim Analysis ◽  
Japanese Patients ◽  
Small Cell ◽  
Surveillance Study ◽  
Postmarketing Surveillance ◽  
Small Cell Lung ◽  
Postmarketing Surveillance Study

scholarly journals Final safety and efficacy of erlotinib in the phase 4 POLARSTAR surveillance study of 10 708 Japanese patients with non‐small‐cell lung cancer

2014 ◽  
Vol 105 (12) ◽  
pp. 1584-1590 ◽  
Author(s):  
Akihiko Gemma ◽  
Shoji Kudoh ◽  
Masahiko Ando ◽  
Yuichiro Ohe ◽  
Kazuhiko Nakagawa ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Japanese Patients ◽  
Small Cell ◽  
Surveillance Study ◽  
Small Cell Lung ◽  
Safety And Efficacy

scholarly journals Retrospective analysis of Japanese patients with relapse or refractory small-cell lung cancer treated with amrubicin hydrochloride

2010 ◽  
Vol 1 (3) ◽  
pp. 569-572 ◽  
Author(s):  
YOUNG HAK KIM ◽  
TADASHI MIO ◽  
KATSUHIRO MASAGO ◽  
KAORU IRISA ◽  
YUICHI SAKAMORI ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Retrospective Analysis ◽  
Cell Lung Cancer ◽  
Japanese Patients ◽  
Small Cell ◽  
Small Cell Lung
Sign in / Sign up

Export Citation Format

Share Document